The Omission of Axillary Lymph Node Dissection in Sentinel Node-Positive Breast Cancer Patients Requires Careful Consideration
Journal Title: International Journal of Cancer and Clinical Research - Year 2017, Vol 4, Issue 2
Abstract
Sentinel Node Biopsy (SNB) is used to accurately assess axillary lymph node status in patients with node-negative breast cancer. The purpose of this study was to assess the association between Non-Sentinel Node (SN) metastasis and clinicopathological findings in patients with one or two SN-positive breast cancer. We evaluated 132 patients with one or two SN-positive breast cancer and 25 patients (19%) had metastatic non-SNs. Positive non-SN metastasis was associated with the HER2 positive (P = 0.035), tumor size (P = 0.06) and equal number of excisional SN and positive SN (P = 0.003). When considering omitting the dissection in SN-positive patients, it is essential to carefully consider the number of removed SNs. Moreover, particular caution is required when considering whether to omit the dissection in patients with tumors exhibiting diameters of > 2 cm or HER2-overexpressing.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP352237
- DOI 10.23937/2378-3419/1410086
- Views 144
- Downloads 0
Physiological Effort in Submaximal Fitness Tests Predicts Weight Loss in Overweight and Obese Men with Prostate Cancer in a Weight Loss Trial
Background Obesity and weight gain after the diagnosis of prostate cancer are associated with an increased risk of prostate cancer recurrence and mortality; individualized plans to help prostate cancer survivors maintain...
Bioactive Peptides from Legumes as Anticancer Therapeutic Agents
Food proteins are a source of nutraceutical and bioactive peptides that promote health and prevent diseases. Legume seed proteins have been widely studied to produce peptides (protein fragments) with a diversity of biolo...
Clinical Utility of Serum Human Epidermal Growth Factor Receptor Type 2 Testing as a Marker of Therapeutic Response In Tissue HER2-Positive Breast Cancer Patients
Background Human Epidermal growth factor Receptor type 2 (HER2) is over expressed in 20.0-30.0% of breast cancers and is currently evaluated histopathologically. Immunohistochemistry and fluorescence in situ hybridizatio...
Ipilimumab Activity in Advanced Uveal Melanoma: A Pooled Analysis
Background Uveal Melanoma is a rare tumour that displays different clinical behavior and molecular features compared with cutaneous melanoma. It is generally resistant to systemic therapy and there is no current standard...
Immune Paralysis and the Spontaneous Remission of Cancer
Once a malignant growth grows past a certain size immune tolerance rather than immune sensitization occurs possibly due to the slow tumor growth. As the malignant grows larger some branches of the immune system (adoptive...